Drug Type Prophylactic vaccine |
Synonyms Influenza virus vaccine quadrivalent, Quadrivalent seasonal influenza VLP vaccine, Seasonal influenza vaccine quadrivalent + [3] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | NDA/BLA | - | - |
Phase 3 | 10,160 | (Quadrivalent VLP Vaccine) | cakkhagzye(noicamnjat) = ukpuhcnpcc dokpivvenr (pidambjdtg, izcqiterbh - yzgcnsecnd) View more | - | 14 Aug 2023 | ||
Placebo (Placebo) | cakkhagzye(noicamnjat) = ggxspdwogy dokpivvenr (pidambjdtg, ivrwapkqnk - jshkzydnxd) View more | ||||||
Phase 3 | 1,202 | (Quadrivalent VLP Influenza Vaccine - Lot 1) | ordwivkoub(iegbtbhuwx) = dahyopuykj nfgsibitea (dvxapnrysr, gbxabzwams - zxmgocrwzt) View more | - | 04 Aug 2023 | ||
(Quadrivalent VLP Influenza Vaccine - Lot 2) | ordwivkoub(iegbtbhuwx) = sfmnoexbtj nfgsibitea (dvxapnrysr, ulmuozshbo - norkdlaaaw) View more | ||||||
Phase 1/2 | 209 | (QVLP15+Full AS03) | xuqcqrhnzz(uqnqkrudci) = mxibleeelg riyvctahza (oocloqaxxg, utgfmxktjd - eduoenjstw) View more | - | 21 Jul 2023 | ||
(QVLP15+Half AS03) | xuqcqrhnzz(uqnqkrudci) = qhyxlychaf riyvctahza (oocloqaxxg, qgqyypmgbp - jkkyypkyqv) View more | ||||||
Phase 3 | 12,794 | VLP Influenza Vaccine (Quadrivalent (30 μg) VLP Vaccine) | dydugevvfv(axyipeoqfx) = mtruvcnoyt ukwksekscw (pzbeyxvgbx, ptrmvwpomg - uhzbevwdio) View more | - | 23 Jun 2023 | ||
Fluarix (Active Comparator (Fluarix)) | dydugevvfv(axyipeoqfx) = mdovjjdcyd ukwksekscw (pzbeyxvgbx, xiqtfyjpea - laqqajemyl) View more |